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Abstract
Developmental genes are often regulated by multiple enhancers exhibiting similar spatio-
temporal outputs, which are generally considered redundantly acting though few have been
studied functionally. Using CRISPR-Cas9, we created deletions of two enhancers, brk5’ and
brk3’, that drive similar but not identical expression of the gene brinker (brk) in early Dro-
sophila embryos. Utilizing both in situ hybridization and quantitative mRNA analysis, we
investigated the changes in the gene network state caused by the removal of one or both of
the early acting enhancers. brk5’ deletion generally phenocopied the gene mutant, including
expansion of the BMP ligand decapentaplegic (dpp) as well as inducing variability in amnio-
serosa tissue cell number suggesting a loss of canalization. In contrast, brk3’ deletion pre-
sented unique phenotypes including dorsal expansion of several ventrally expressed genes
and a decrease in amnioserosa cell number. Similarly, deletions were made for two enhanc-
ers associated with the gene short-gastrulation (sog), sog.int and sog.dist, demonstrating
that they also exhibit distinct patterning phenotypes and affect canalization. In summary,
this study shows that similar gene expression driven by coacting enhancers can support dis-
tinct, and sometimes complementary, functions within gene regulatory networks and, more-
over, that phenotypes associated with individual enhancer deletion mutants can provide
insight into new gene functions.
Author summary
Genes expressed during development are often regulated by multiple cis-regulatory
sequences, non-coding DNA, also known as enhancer sequences. Many instances have
been found where two or more distinct enhancer sequences support similar spatiotempo-
ral outputs relating to a single gene. These enhancers have generally been considered
redundantly acting, or overlapping in activity, though few have been studied functionally.
We created deletions of coacting enhancer pairs associated with the genes brinker (brk)
and short-gastrulation (sog) from the genome of D. melanogaster fruit fly using CRISPR-
Cas9 genome editing. Surprisingly, opposite phenotypes relating to some target genes are
associated with the enhancer deletions. Deletion of one enhancer generally exhibits
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phenotypes in early embryo patterning similar to respective gene mutants; whereas, in
contrast, deletion of the other presents unique phenotypes including change in cell num-
ber for a particular tissue in the embryo, the amnioserosa. In summary, this study shows
that coacting enhancers driving similar expression outputs can support distinct, and
sometimes complementary, functions to differentially impact the development of embryos
and that the individual mutation of these enhancers can provide insight into new gene
functions.
Introduction
It has been demonstrated that many developmental genes are associated with a number of
enhancers that support similar or overlapping spatiotemporal gene expression patterns,
termed “shadow” or “sibling” enhancers [1,2]. To provide insight into their roles, studies of
these coacting cis-regulatory elements have ranged from assay of individual enhancer activity
in the context of small reporter genes to whole-genome approaches in which conservation of
sequence was used as a proxy for function. The first study that coined the term shadow
enhancer focused on two genes in Drosophila embryos, brinker (brk) and short gastrulation
(sog), which are each associated with two enhancers that control their expression in the early
embryo [1]. These enhancers drive expression in overlapping domains when evaluated by
reporter assay, suggesting that their roles are either redundant or overlapping in function. Sub-
sequently, studies of such coacting enhancer pairs associated with other genes have found that
individual enhancers within a pair are conditionally required, as single enhancer mutants are
viable under normal conditions but both enhancers are required to support robustness under
adverse conditions, such as genetic perturbation or stressful environmental conditions [e.g.
3,4,5]. On the other hand, a whole genome study of shadow enhancers found that these coact-
ing sets of enhancers exhibit higher sequence conservation suggesting they also likely have
some non-redundant functions [6].
In Drosophila, large reporter constructs allow assay of the role of individual enhancers in
supporting gene expression in the context of the intact cis-regulatory systems. For example,
large reporter constructs were used in live imaging experiments to determine that at some loci,
such as knirps, coactive enhancers can function in an additive way in terms of gene output;
while at other loci (hunchback in anterior regions, and snail), the function of enhancers is sub-
additive: as the combined activity of the two-acting enhancers assayed is less than the sum of
each individual enhancer [7,8]. Similarly, the proper expression domains of a gene are also
dependent on the cooperation between coacting enhancer pairs, requiring both enhancers for
precise patterning [2,9]. Therefore, coacting enhancers pairs can either synergize or compete
to regulate levels or spatial output of gene expression.
For the gene brinker (brk), it appears that the two enhancers regulating expression in the
early embryo are co-active for only a short period of time [10]. The 5’ enhancer (brk5’, also
known as 5’CRM or brkNEE), located ~10 kB upstream of the promoter, acts first to support
expression in a thin lateral stripe along the dorsal-ventral (DV) axis and the 3’ enhancer (brk3’
also known as 3’CRM or brk shadow), located ~10 kB downstream of the promoter, acts subse-
quently to support expression in a broad lateral stripe [1,11–13]. Through deletion analysis in
the context of large reporter constructs, our previous analysis showed that the brk5’ and brk3’
enhancers act in series and that the switch is regulated by a promoter proximal element [10].
Furthermore, the brk gene expression pattern changes in time from a thin lateral stripe to one
that is broad [14,15], presumably, relating to sequential action of the brk5’ and brk3’ enhancers.
Coacting enhancers can have complementary functions
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As a result of this previous study, we hypothesized that the spatiotemporal change in brk gene
expression supported by serial action of these two enhancers, though subtle, might relate to
different roles of Brk protein, which functions as a transcriptional repressor [e.g. 14]. Never-
theless, it was left untested in previous studies how brk early embryonic enhancers individually
impact Brk-dependent functions, as the large reporter constructs did not preserve Brk function
but instead the gene was replaced by reporter gene gfp.
New advances in genome editing present the opportunity to functionally examine roles for
individual enhancers in native context. Here we conducted an analysis of phenotypes associ-
ated with enhancer mutants for brk as well as sog, created using CRISPR-Cas9 [rev. in 16] to
delete these sequences from the endogenous locus, and assayed their individual and combined
roles to provide insight into the function of coacting enhancers.
Results
Deletion of brk early embryonic enhancers supports viability but uncovers
amnioserosa defect
To start, we used CRISPR-Cas9 to delete two enhancers, brk5’ and brk3’, from the native brk
locus (Fig 1A). Surprisingly, flies containing deletion of either enhancer individually (brkΔ5’
or brkΔ3’) or both together (brkΔ5’Δ3’) are viable and therefore embryos obtained from homo-
zygous mutant stocks were characterized. Expression supported by these enhancers, through
lacZ gene reporter assay (Fig 1C and 1D;[10]), was compared with resulting brk gene expres-
sion in mutant embryos containing deletion of one or both enhancers. Deletion of the
enhancer located upstream (brkΔ5’) leads to a loss of the early narrow pattern (early st5 Fig 1E,
compare with 1B); deletion of the enhancer located downstream (brkΔ3’) leads to a loss of the
later, broad pattern (late st5 Fig 1F); and deletion of both brk5’ and brk3’ enhancers
(brkΔ5’Δ3’) leads to a complete loss of brk expression in the cellularized embryo at stage 5 (Fig
1G). These observations agree with a previous analysis where deletions of these enhancers
were made within a large reporter construct in which the brk coding sequence was replaced
with gfp [10]. Additionally, the deletions made at the native locus permit extension of the ear-
lier study by allowing analysis of phenotypes resulting from perturbed brk expression. When
viability at the embryonic stage specifically was examined (see Methods), we found that there
was a slight increase in embryonic lethality compared to wildtype in each of the single mutant
embryos but, surprisingly, more than 85% of embryos were viable (S1A Fig).
To provide insight into how these enhancer sequences support Brk function, we examined
embryonic phenotypes linked to brk- gene mutants. Previous studies of brk- gene mutant phe-
notypes had suggested that early brk expression is responsible for defective patterning of the
ventral ectoderm at stage 9 [17]. This change presents as a reduction in snail gene (sna)-
expressing neuroblasts as well as a loss of ventral denticle bristles in the cuticle in the ventral
neurogenic region (brk-, Figs 1H, 1I and S1B). However, the early embryonic brk enhancer
deletions had little to no effect on either neuroblast specification (Fig 1I) or denticle band for-
mation (Figs 1H and S1B). We observed that in all three enhancer mutant lines brk expression
is restored by stage 8/9 (st8/9; Fig 1E–1G). Therefore, other enhancer(s) likely support Brk’s
role at later stages. Furthermore, as brk- gene mutants are zygotically lethal but embryonic
enhancer deletions are not, brk gene activity at a later stage of development likely is required to
support viability [18]. Consequently, these early embryonic enhancer deletions allowed us to
analyze the specific contribution of Brk activity in the cellularizing embryo to later
phenotypes.
Previous studies have shown that specification of amnioserosa, an extraembryonic tissue
that serves as a structural support during germ band elongation and retraction during embryo
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Fig 1. Pre-gastrulation expression of brk is not required for viability but deletion of the brk3’ enhancer leads to a loss of amnioserosa specification. (A) Genomic
locus of brk indicating the location of the brk5’ and brk3’ enhancers relative to the brk gene coding sequence. (B-E) In situ hybridization using brk (B,E-G) or lacZ (C,D)
riboprobes detected by alkaline phosphatase (AP) on (B) wildype (WT), (C) brk5’-lacZ reporter, (D) brk3’-lacZ reporter, (E) brk Δ5’, (F) brk Δ3’, and (G) brk Δ5’Δ3’
embryos. In this and all subsequent figures, unless otherwise indicated, all embryos are lateral view with anterior to the left and dorsal on top. The top row shows the
narrow lateral expression of brk during early stage 5 that is primarily driven by the brk5’ enhancer. The middle row shows the broad lateral pattern of brk expression at
late stage 5 which is lost when the brk3’ enhancer is deleted. The bottom row are stage 8 or 9 embryos which all express brk in the ectoderm. (H) Dark field images of
lateral view of cuticle preps from first instar larvae. Only the brk- gene mutant embryos show a loss of ventral denticle bristles. (I) Fluorescent in situ hybridization
(FISH) against sna riboprobe in the ventral neurogenic ectoderm of stage 9–11 embryos, anterior up and posterior down. The WT and brk CRISPR-Cas9 mutants all
show three rows of sna expressing central nervous system (CNS) cells on either side of the midline with 2–3 peripheral nervous system (PNS) cells per segment
extending out laterally. Only the brk- gene mutant embryos show a loss of the third row of sna expressing cells in the CNS (grey arrow). (J) Lateral view of stage 10–13
embryos immunostained for Hnt to mark the amnioserosa cells. Gaps in the brk Δ3’ amnioserosa marked with yellow arrow. (K) Number of amnioserosa cells on the
lateral side of the embryo for each of the genotypes. The number of amnioserosa is significantly different from WT in the brkΔ5’ embryos (� P = 0.03, Welsh’s t-test) and
the brkΔ3’ (�� P = 1.5x10-7, Welsh’s t-test), but not in the brkΔ5’Δ3’ or brk- (P = 0.8 and P = 0.2, respectively, Welsh’s t-test) For this and subsequent box plots, the center
lines show the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th
and 75th percentiles, outliers are represented by dots; crosses represent sample means; data points are plotted as open circles. Number of embryos counted shown under
genotype.
https://doi.org/10.1371/journal.pgen.1008525.g001
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morphogenesis [19], is not affected in brk gene mutants [17]. Using Hindsight (Hnt) anti-
body to label amnioserosa cells, we confirmed that neither the brk- gene mutant nor the
brkΔ5’Δ3’ enhancer deletion mutant has significantly different amnioserosa cell numbers
compared to wildtype (Fig 1J and 1K). We did, however, observe higher variability in cell
number in these two genotypes compared to wildtype (Fig 1K; Levene’s test for equality of
variance (Levene’s): brkΔ5’Δ3’ P = 0.02; brk- P = 0.007). In contrast, amnioserosa cell num-
ber in brkΔ3’ embryos is significantly lower than wildtype with large empty areas visible
within the field of amnioserosa cells (Fig 1J arrow, Fig 1K; Levene’s: brkΔ3’ P = 0.04).
Amnioserosa cell number in the brkΔ5’ is also significantly different from wildtype, being
lower on average, but additionally more variable with some embryos having more cells than
wildtype (Fig 1J and 1K, brkΔ5’; Levene’s: P = 0.005). These findings indicate that brk does
affect amnioserosa specification. As BMP signaling, specifically high level output via ligand
Decapentaplegic (Dpp), is thought to directly relate to amnioserosa specification [20], these
results also suggest brk expression impacts high level Dpp signaling outputs. The fact that
amnioserosa is a transient structure, undergoing cell death after germ band retraction [19],
helps to explain how the variability in amnioserosa cell number observed in these enhancer
mutants can be tolerated and compatible with embryo viability. Nevertheless, these different
amnioserosa phenotypes associated with individual enhancer deletions reveal new and dis-
tinct roles for Brk in supporting early embryonic patterning that could not be identified
using brk- gene mutants (see Discussion).
The unexpected fact that the brkΔ5’Δ3’ embryos had milder defects than the single
enhancer deletions hinted at a compensatory mechanism and led us to investigate the effects
of brk driven by the individual enhancers within the gene network of the early embryo.
Both enhancers are required to properly regulate canonical Brk target
genes’ early expression and to establish dpp dosage
It has been shown that direct repression by Brk is important to establish the proper expression
pattern of the dpp gene as well as several Dpp target genes [14,20]. The most studied of these
Brk/Dpp target genes are zen, tld, and pnr. We therefore looked at the expression pattern of
these four genes in each of the brk gene and enhancer mutant backgrounds (see Fig 2A–2D).
brkΔ5’Δ3’ mutant embryo phenotypes were consistent with brk- gene mutants with the dpp,
zen, pnr and tld expression domains expanded all the way to the dorsal border of snail (sna),
on the ventral side of the embryo. brkΔ5’ mutants show a milder defect, but similar trend, with
all four target genes slightly expanded. The brkΔ3’ mutants, upon first observation show no
clear expansion of any of these early target genes.
However, upon closer scrutiny, all of the mutants, including brkΔ3’, have an effect on dpp
when expression dynamics are taken into consideration (see Fig 2E). The wildtype expression
domain of dpp encompasses about 47% of the embryo circumference at early stage 5, and by
late stage 5 is refined to around 41%. In the brkΔ3’ embryos, the extent of the dpp expression
domain is not significantly different from wildtype at early stage 5; however, it fails to refine at
late stage 5. Collectively, these data demonstrate that brk is required both for the proper estab-
lishment of the dpp expression domain in early stage 5 (brk5’ primary) as well as the refine-
ment of the domain throughout stage 5 (brk3’ primary) to regulate dpp dosage and impact
BMP signaling at stage 6.
However, amnioserosa specification relies on input from Dpp but also on other genes. The
lack of refinement in brkΔ3’ mutants is not likely to explain why amnioserosa cell number is
low in this mutant background, specifically. We turned toward analysis of other genes acting
to support patterning in order to determine if any changes were specific to loss of the brk3’
Coacting enhancers can have complementary functions
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enhancer that could explain why amnioserosa cell counts are low in this particular mutant
background.
NanoString data supports the view that some genes are regulated by brk
activity driven by both enhancers whereas others are regulated
predominantly by the brk3’ enhancer activity
We conducted a quantitative analysis of target gene RNA levels using NanoString technology
in order to provide further insight into the role of individual brk enhancers in the regulation of
gene expression [21]. The NanoString system permits precise quantification of transcripts
across five orders of magnitude from a single embryo without the need to fragment, amplify,
or reverse transcribe the RNA. In a previous study, we used expression of ~70 genes represent-
ing pivotal patterning genes active in early embryos to assay the dorsal-ventral patterning gene
regulatory network state in the early embryo [22]. This method facilitates assay of temporally-
precise samples, which for Drosophila embryos is challenging as embryonic development can-
not be synchronized within larger collections.
Individual embryos of wildtype or brk enhancer mutant backgrounds were assayed for gene
expression profiles at one timepoint during late stage 5 [nuclear cycle (nc) 14C] when both
enhancers should be active (Fig 3A, see Materials and methods). Quantitative mRNA data was
compared for four genotypes: wildtype (WT: yw), brkΔ5’, brkΔ3’, and brkΔ5’Δ3’. First, as proof
of principle, total counts of brk mRNA were measured and, as expected, the brkΔ5’ data is sim-
ilar to wildtype (as the brk3’ enhancer is predominantly acting at late stage 5), whereas counts
are decreased for the brkΔ3’ and brkΔ5’Δ3’ datasets (Fig 2F). The brkΔ5’Δ3’ counts are the low-
est, supporting the view that the brk5’ enhancer is partially active at this stage as well. Despite
the lack of detectable staining in these mutants at nc14C, however, the NanoString counts for
brkΔ5’Δ3’ are non-zero. This could indicate that there is low level maternal, ubiquitous tran-
script in these embryos or that a different enhancer drives low-level expression that we are
unable to visualize by in situ.
The NanoString approach serves as a sensitive, quantitative method to investigate how gene
expression supported by individual enhancers may have additive (i.e. phenotypes of increasing
severity) or antagonistic effects (i.e. opposite phenotypes) on target gene expression outputs.
NanoString allows us to detect mRNA abundance, which is complementary to the spatial data
provided by stainings. For example, dpp levels show a consistent trend between area of expres-
sion, visualized by in situ hybridization (Fig 2A and 2E), and levels of expression as measured
by NanoString (Fig 2F). During late stage 5, the brkΔ5’Δ3’ mutant has both the highest level
and the broadest domain of dpp expression. The brkΔ5’ mutant also shows increased dpp levels
compared to wildtype, though not as high as the double deletion, consistent with the partial
spatial expansion of the dpp expression domain seen in this mutant (Fig 2F, compare with 2A
Fig 2. Proper expression of brk at early stage 5 is required for setting the ventral boundary of dpp and BMP target genes. (A-B) FISH using an (A)
intronic dpp probe (white) or (B) zen (purple) and rho (green) probes on manually chopped cross-sections of late stage 5 embryos. White arrowheads
indicate the ventral most cell expressing dpp (A) or zen (B) on either side of the embryo. (C) Early stage 6 embryos with riboprobes to sna (red) and tld
(white). The ventral extent of tld expression is indicated with white arrowheads. (D) AP detection of pnr riboprobe on early stage 6 embryos. Expansion of
the lateral stripes towards the ventral side of the embryo is indicated with white arrowheads. (E) Quantification of the percentage of embryo
circumference expressing dpp in early stage 5 and late stage 5 embryos. The percentage of the embryo circumference expressing dpp was quantified using
5–7 cross-sectioned embryos per stage of each genotype (see Materials and methods). Mutant genotypes were compared to WT embryos of the same
stage. Black asterisk indicates that the measurement is significantly different from the early stage 5 WT embryo (P = 0.005 late stage 5 WT, P = 0.008
brkΔ5’, P = 0.2 brkΔ3’, P<0.00001 brkΔ5’Δ3’), and grey asterix indicates the same for the late stage 5 embryos (P = 0.002 brkΔ5’, P = 0.02 brkΔ3’,
P<0.00001 brkΔ5’Δ3’; indicated in the graph as �P<0.05, ��P<0.01, ���P<0.0001, Student’s t-test). (F) NanoString results for brk, dpp, sog, and tld in
nc14C (late stage 5) embryos (see Materials and methods). For this and all subsequent NanoString graphs, the results are given in arbitrary units and the
SEM for 6 (WT, brk Δ5’Δ3’) or 5 (brk Δ3’, brk Δ5’) individual embryos are shown by black bars.
https://doi.org/10.1371/journal.pgen.1008525.g002
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Fig 3. NanoString uncovers both additive and brk3’ enhancer-specific gene expression effects. (A) Illustration of changing contribution of the activity driven by the
brk3’ (blue), brk5’ (gold), and later acting brk enhancers (green) to the brk expression pattern during early stages of development. All embryos for NanoString were
collected at nc14c. Genes assayed by in situ hybridization in this study are listed under the developmental stage in which they were analyzed. (B) Graphical
representation of NanoString results from nc14C embryos showing genes in which there is an additive effect with the highest level of expression in the brk Δ5’Δ3’
embryos. (C) FISH staining using tll riboprobe on late stage 5 embryos. Expansion of tll expression in posterior indicated by white arrows. (D) AP detection of aos
riboprobe on early stage 6 embryos. Red arrows mark ventral-most expression of aos head stripe in each genotype. (E) NanoString targets that show a significant
upregulation in the brkΔ3’ embryos. (F-I) Ventral view of late stage 5 embryos hybridized to riboprobes for (F) intronic NetA, (G,H) intronic NetA and twi, or (I)
Coacting enhancers can have complementary functions
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and 2E). The brkΔ3’ embryos show a dpp expression level similar to, if slightly increased over
wildtype, in agreement with the lack of refinement of the dpp expression domain between
early and late stage 5 in this genotype (Fig 2F, compare with 2A and 2E). However, for some
other Brk targets, we observe a lack of correlation between levels and expression domain. For
example, tld expression is equivalently increased in both the brkΔ5’ and brkΔ3’ embryos
according to the NanoString data, although we observe spatial expansion of expression only in
brkΔ5’ embryos (Fig 2F, tld, compare with 2C). The parallel analysis of gene expression on
both area (in situ hybridization) and level (NanoString) of expression allowed us to more fully
investigate the changes in gene regulation in these mutant embryos (Fig 3A).
brk encodes a transcription factor that acts as a transcriptional repressor to limit BMP sig-
naling and support patterning in the early embryo and at other stages of development includ-
ing in the wing disc [11,14]. In this role, it has been shown that brk functions redundantly with
short gastrulation (sog), a homolog of chordin in vertebrates, which encodes another inhibitor
of signaling acting in the extracellular space [17,23]. As both Brk and Sog regulate BMP signal-
ing outputs activated by Dpp ligand, we hypothesized that sog may be able to compensate for
compromised brk enhancer function in early embryos. Indeed, late stage 5 expression of sog is
affected in brk enhancer mutants (Fig 2F). The brkΔ5’ embryos show near wildtype levels, but
the sog expression is significantly increased in the brkΔ3’ and brkΔ5’Δ3’ embryos. These com-
pensatory changes in sog levels may act to rescue decreases in brk and serve as a partial expla-
nation for the viability of embryonic brk enhancer mutants (see Discussion).
Among the set of patterning genes studied using NanoString, a small set appeared to respond
in what appears to be an additive manner, in terms of target gene expression phenotype severity,
in brk enhancer mutants. Individual deletions each result in slight expression changes which are
amplified in brkΔ5’Δ3’ embryos (Fig 3B). This set of genes is diverse in both the expression
domains as well as the pathways in which they function. They include Neu3 (Meltrin), which
encodes a metalloprotease and is expressed in a pattern largely overlapping with brk, as well as
more broadly-expressed genes such as capicua (cic) and runt (run) which encode transcription
factors [24–26]. Even anterior-posterior regulated genes, such as the transcription factor tailless
(tll) [27], are upregulated, and this change can be seen as tll expression is visibly expanded pos-
teriorly in brkΔ3’ embryos and even more so in the brkΔ5’Δ3’ embryos (Fig 3C, white arrows).
NanoString also highlighted two known brk targets from the EGFR pathway, Egfr and argos
(aos) [28]. aos shows a similar additive regulatory trend, with slight expansion of the anterior
stripes in the brkΔ5’, slightly more derepression in this region in the brkΔ3’, and full expansion
of these stripes towards the ventral side of the embryo in brkΔ5’Δ3’ (Fig 3D, red arrows).
While our analysis identified no genes that show significant upregulation in brkΔ5’ com-
pared to the other genotypes (S2 Fig), a number were significantly upregulated in the brkΔ3’
embryos including several genes that are ventrally-expressed in the embryo, within the pre-
sumptive mesoderm (Fig 3E). The gene NetA [29] shows the largest difference in expression
levels in the brkΔ3’ embryos, as compared to the other backgrounds (Fig 3E). Lateral expres-
sion of NetA outside of the presumptive mesoderm (marked by twi expression) is expanded in
brkΔ3’ embryos, especially in the anterior third of the embryo (Fig 3F and 3H). In addition,
the expression domain of NetA is expanded in the posterior in both the brkΔ3’ and the
brkΔ5’Δ3’ embryos (Fig 3G, arrows). This posterior expansion tracks with brkΔ3’ and suggests
stumps. (G) is a magnified view of the posterior of the embryo shown in (E) showing NetA (green) expression as well as twi (red) expression to mark the mesoderm;
expansion into the posterior marked by white arrows. Similarly (H) is a magnified image of the mesoderm boundary towards the anterior of the embryo. The expression
of stumps (I) has been false colored with a heatmap (scale shown to the right with red highest and black lowest expression, see Materials and methods). Areas of
expanded expression indicated with red arrows.
https://doi.org/10.1371/journal.pgen.1008525.g003
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that late Brk expression supported by the 3’ enhancer may be required for terminal patterning
(i.e. posterior NetA expansion relates to an indirect effect). Another ventrally-expressed gene,
stumps, also appears expanded in lateral regions specifically in embryos mutant for brk3’ (Fig
3I, red arrows). These data indicate a previously undescribed role for brk in which proper
expression of brk in late stage 5, which is primarily supported by brk3’, is required for setting
the dorsal boundary of some ventrally expressed genes.
To determine if these observed phenotypes relate to direct action by Brk, we examined pub-
lished Brk chromatin immunoprecipitation data [ChIP-seq; 28] for two different timepoints,
2–2.5 hr and 3–3.5 hr, roughly corresponding to early and late stage 5, respectively, and repre-
senting primarily brk5’- (2–2.5 hr) or primarily brk3’- (3–3.5 hr) driven brk expression. These
data show Brk binding at the NetA and stumps loci primarily during late stage 5 but not signifi-
cantly during early stage 5 [28], supporting the view that the brk3’-driven brk expression is
responsible for regulating these genes (S3 Fig). Notably, though, in both NetA and stumps, we
see a greater overall increase in expression (Fig 3E) and visible expansion into the neuroecto-
dermal tissue in the trunk of the embryo in the brkΔ3’ compared to the brkΔ5’Δ3’ (Fig 3F, 3H
and 3I). This lack of expansion in the double deletion could be an indirect effect of the loss of
brk expression driven by the two early acting enhancers, possibly relating to the expanded
domain of dpp expression in these embryos that could either directly or indirectly repress the
expression of these ventrally expressed genes. Again, we find an instance where the double
enhancer deletion exhibits a more mild defect than the single deletion.
In summary, these NanoString data support the view that Brk transcription factor activity
driven by the brk3’ enhancer is exclusively required to regulate a subset of genes, and demon-
strate that the brk5’ and brk3’ enhancers have important, nonredundant functions during
development. Furthermore, as a set of genes exhibits comparable gene expression in brkΔ5’
and brkΔ5’Δ3’ mutants but distinct outcomes in the brkΔ3’ mutant (Fig 3E), the brk3’ enhancer
may function to balance action of the brk5’ enhancer. Loss of the brk3’ enhancer makes a dif-
ference only if the brk5’ has acted first to establish a wildtype gene regulatory environment and
suggests these two enhancers act in a complementary manner.
Differential BMP target gene expression in brk mutants results from
differences in gene regulatory network state in these mutants
Nanostring as well as in-situ analysis of the brk mutants revealed varying expression of effec-
tors and known regulators of BMP signaling (Figs 2A–2F and S2). Similarly, we observed dif-
ferential specification of amnioserosa cells, which are specified by peak BMP signaling, in the
three mutant lines (Fig 1J and 1K). Therefore, we analyzed BMP signaling and resulting target
gene expression in these mutants to assess the impact on the broader gene regulatory network.
Bmp signaling is regulated at many levels: from the production and transport of the ligand
to the dorsal midline, binding and activation of the receptors, and finally the phosphorylation
of Mad and its import into the nucleus to initiate transcription of target genes [rev. in 30,31].
Once produced, the transport to and concentration of Dpp at the dorsal midline requires a set
of proteins including Sog, Twisted gastrulation (Tsg), and Tld [32]. Sog forms a complex with
the ligands, Dpp and Scw, aided by Collagen IV which can act as a scaffold for BMP-Sog bind-
ing (Fig 4G (1), [33]). The binding of Tsg to this complex releases it from the Collagen IV and
allows for its movement and promotes the long range shuttling of the ligand (Fig 4G (1) and
(2), [34]). Free Dpp and Scw ligands are released from the Sog-Tsg complex through cleavage
of Sog by the protease Tld (Fig 4G (3), [35]). After being released from the Sog-Tsg complex,
Dpp is then free to bind to and activate the BMP receptors [Fig 4G (4)], leading to the phos-
phorylation of Mad. In wildtype embryos Dpp activity, commonly quantified by measurement
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Fig 4. pMad gradient is expanded in brk mutants but BMP target gene expression at late stage 6 does not correspond. (A) Dorsal view of early stage 6 embryos
immunostained with pMad antibody. Z-projection is false colored with a heatmap (key indicated to the right, red highest, black lowest expression, see Materials and
methods). (B-E) Dorsal view of FISH (B,D) or AP stained (C,E) in situs against riboprobes to (B) egr, (C) rho, (D) Race, and (E) zen. Expanded rho expression in brk Δ5’
embryo indicated by white bracket. All embryos are stage 6 unless otherwise noted. (F) Quantification of pMad gradient. Width was measured at 40% maximum of WT
pMad gradient (see Materials and methods). Width of the pMad gradient is significantly different from WT in the brk Δ5’ (Welch’s t test: t = 18.8, df = 7.4,
���P<0.0001), in the brkΔ3’ (Welch’s t test: t = 13.0, df = 8.0, ���P<0.0001) and in the brk Δ3’,brkΔ5’ embryos (Welch’s t test: t = 31.3, df = 8.4, ���P<0.0001). (G)
Graphic representation of some of the key effectors and target genes expressed through BMP signaling in the early embryo. (1) On the dorso-lateral side of the embryo
Dpp dimers form a complex with Sog, bound to collagen; Tsg binds to this complex and releases it from the collagen matrix so that it can (2) diffuse dorsally. (3) Tld
cleaves Sog and releases Dpp from the complex so that it can (4) bind to the BMP receptors and activate the phosphorylation of Mad. (5) Phosphorylated Mad binds to
the co-Smad, Medea, and enters the nucleus. (6) pMad and Medea initiate transcription of target genes, some of which have either positive (egr) or negative (rho/EGFR
signaling) feedback into BMP signaling. The changes in gene expression of key effectors and target genes in each of the mutants compared to WT as determined by in
situ and/or NanoString data is depicted by arrows. (H) Box plot of width of rho expression domain measured as percentage of the embryo circumference. (see Materials
and methods) (P = 0.01 brkΔ5’, P = 0.002 brkΔ3’, P = 0.0048 brkΔ5’Δ3’; in graph indicated by �P<0.01, ��P<0.005 Welsh’s t test).
https://doi.org/10.1371/journal.pgen.1008525.g004
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of phosphorylated Mad (pMad [36]), is restricted to a narrow peak at the dorsal midline. After
phosphorylation, pMad binds to the co-Smad, Medea, and enters the nucleus where it activates
target gene expression [Fig 4G (5) and (6)].
Brk can affect the steps in this pathway both directly and indirectly. We have shown that
deletion of either of the two brk enhancers alone, or both together, have differential impacts
on the production of Dpp (Fig 2E). In addition, in all the brk enhancer mutants, both sog and
tld expression levels are increased (Fig 2F), while tsg is downregulated (S2 Fig) with expression
in the middle of the embryo lost in the brkΔ5’ and brkΔ5’Δ3’ deletions (S4A Fig). To determine
the effect of these changes in gene expression domains on BMP signaling within brk mutants,
we measured the width of the pMad gradient for each mutant at early stage 6. Similar to the
results for dpp and early brk target genes (Fig 2), the pMad gradient is significantly widened in
brkΔ5’ embryos (53.6 ± 4.4 μm) and in brkΔ5’Δ3’ embryos (62.3 ± 2.7 μm) compared to the
WT (27.9 ± 1.3μm) (Fig 4A and 4F). The gradient is also wider in brkΔ3’ embryos, but to a
lesser extent (43.5 ± 2.9 μm; Fig 4A and 4F). The differential effects on regulators of BMP sig-
naling in these mutant backgrounds provides insight into the differences observed in pMad
expression, as the ratio of expression levels between the functional activators (dpp, tld, and tsg)
to the inhibitor (sog) is different in the three mutant backgrounds.
Several targets of BMP signaling have previously been shown to have either positive (i.e.
egr) or negative (i.e. EGFR signaling) feedback into BMP signaling and the formation of the
pMad gradient. The BMP target gene egr has been shown to be a necessary component in the
positive feedback mechanism, which refines and amplifies the pMad expression domain [36].
Inversely, the import of pMad into the nucleus has been shown to be negatively affected by
EGFR signaling. Specifically, it was found that hyperactivated EGFR signaling can directly
inhibit translocation of pMad into the nucleus [37]. Notably, both egr and components of the
EGFR signaling pathway show opposite responses in the brkΔ5’ and brkΔ3’ embryos.
The expression domain of two genes involved in EGFR signaling, rhomboid (rho) encoding
a protease and vein (vn) encoding a ligand, are significantly expanded at the dorsal midline of
the brkΔ5’ embryos (Figs 4C and S4B). It follows that dpERK is also expanded in this mutant
(S4C Fig). As these genes are known targets of BMP signaling, this result is consistent with the
fact that these embryos have higher dpp levels and wider pMad expression domains. The nega-
tive feedback from high levels of EGFR signaling seen in the brkΔ5’ may explain why the wider
pMad gradient in these mutants fails to lead to higher target gene expression such as zen and
Race (Figs 4D, 4E, S4E and S4F). The other brk mutants, however, do not show the same
response. Despite the wider pMad gradient in brkΔ3’, the expression of rho in these embryos is
significantly narrower than wildtype (Fig 4C and 4H). Unexpectedly, the rho and dpERK
expression in the brkΔ5’Δ3’ embryos, although slightly reduced, is the most similar to wildtype
of the brk mutants (Figs 4C, 4H and S4C). In the case of EGFR signaling feedback, it appears
as if half action by Brk is more disruptive than a loss of Brk activity (see Discussion).
Similarly, egr is oppositely regulated in the two single mutants. In the brkΔ3’ mutants the
egr expression domain is expanded; while both the domain and the levels of expression are sig-
nificantly lower in the brkΔ5’ embryos (Fig 4B). As egr is known to refine and concentrate the
pMad gradient, this may in part explain why peak target genes, such as zen and Race (Figs 4D,
4E, S4D, S4E and S4F), are narrower or missing in the brkΔ3’ embryos and subsequently why
the amnioserosa cell number is lower in these mutants. Again, we see that the expression of egr
in the double mutant is somewhat intermediate between the two single mutants (Fig 4B). Sur-
prisingly, the expression of the peak target genes in the brkΔ5’Δ3’ mutants is inconsistent, with
zen being expanded and Race expression disrupted (Figs 4D, 4E, S4D, S4E and S4F).
Brk can affect so many different components of the gene network that a simple model of
the known feedback and feedforward loops can not completely explain the new state created in
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these brk enhancer mutants. Furthermore, the finding that some regulators of BMP signaling
are differentially affected in the brk5’ and brk3’ mutants provide an explanation for why BMP
target gene expression varies in these genotypes, as these target gene outputs reflect an additive
effect of many Brk actions (Fig 4G; see Discussion).
Deletion of shadow enhancers associated with the sog gene also exhibit
opposite phenotypes, distinct from the gene mutant
We hypothesized that shadow enhancers, in general, are able to support complementary activi-
ties. To provide additional support for this idea, we deleted two early embryonic enhancers
driving expression of the gene sog, which has also been characterized as having coacting
enhancers (Fig 5A [1]). At the sog locus, one enhancer is located proximal to the promoter
within the first intron (sog.int) whereas the other is located distally, more than 10 kB upstream
(sog.dist also known as sog.NEE or sog.shadow) (Fig 5A). Both sog.int and sog.dist enhancers
have been shown to support expression in early embryos within a broad lateral stripe with
apparently no difference in their timing of action when examined by reporter gene assay (Fig
5C and 5D, see also [1,38,39]). Similar to the brk enhancer deletions, both the sogΔint and
sogΔdist enhancer deletions are viable; although the double mutant, which exhibits a loss of all
early embryonic expression (Fig 5G), is not viable. Unlike brk, however, deletion of either of
the early sog enhancers did not lead to an obvious change in expression domain of the gene,
but there was a marked difference in expression levels (Figs 5E, 5F and 6A).
Analogous to what has been described at the snail locus [7,8], deletion of the enhancer
more proximal to the gene (sog.int) leads to an increase in expression levels while deletion of
the more distant enhancer (sog.dist) leads to a decrease in expression levels. Also consistent
with the findings from the sna locus [8], the distal enhancer is highly sensitive to repression. In
wildtype embryos in nc14A, sog expression is expanded into the ventral most cells (Fig 5H),
but is quickly excluded from the ventral region by nc14B (Fig 5I), presumably through repres-
sion by Sna [40]. In the sogΔint mutants, however, there is no ventral expression at all in nc14,
while in the sogΔdist mutants this ventral expression is retained until nc14C (Fig 5H and 5I).
As we hypothesized, however, the single enhancer deletions in sog also show opposite phe-
notypes on the larger gene network. Amnioserosa cell number is decreased in the sogΔint
while it is increased on average in the sogΔdist (Fig 5J). The amnioserosa cell numbers for
sogΔdist are similar to those for a sog- gene heterozygous embryo (Fig 5J), further confirming
the determination that the sogΔdist mutation decreases the levels of sog expression. All of the
sog mutant backgrounds except for sogΔintΔdist demonstrated increased variability in amnio-
serosa cell number compared to wildtype (Fig 5J; Levene’s: sog- P = 1.0x10-5, sogΔint
P = 1.0x10-5, sogΔdist P = 2.4x10-4, sogΔintΔdist P = 0.09). The increased variability suggests
that, like Brk, Sog also functions to canalize BMP peak signaling output.
To further characterize these mutants, we looked at the indicator of BMP signaling (pMad)
as well as a peak BMP target gene (Race) and a mid-level BMP target gene (rho). In the sog-
gene mutant, pMad is present at uniform low levels in an expanded area encompassing the
dorsal half of embryos, in contrast to the narrow band of graded expression present in wildtype
embryos (Fig 6B). However, in both sog enhancer mutants, pMad staining is expanded com-
pared to wildtype (Fig 6B). Previous observations and modeling works have shown that BMP
signaling is directly affected by the dosage of sog. When sog is expressed at lower levels, such as
in a heterozygous sog mutant embryo, the pMad expression domain is significantly wider than
wildtype (Fig 6B); conversely, the peak of pMad signal is narrower and lower when an extra
copy of Sog is introduced [41]. The levels of sog are visibly lower in the sogΔdist mutant com-
pared to wildtype (Fig 6A), and the resulting pMad pattern is more broad, consistent with
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heterozygous sog- gene mutant embryos (Fig 6B). In contrast, levels of sog transcript are visibly
increased at stage 6 in the sogΔint mutant background compared to wildtype (Fig 6A), yet the
pMad expression is not narrowed compared to wildtype as one would expect from sog over-
expression (Fig 6B). It is likely that timing, as well as levels of expression of sog are important
for defining the pMad gradient at stage 6.
Downstream BMP target genes are also differentially affected in these mutants. In a sog
gene mutant, expression of Race, a peak level target gene, is lost in the trunk but retained at the
anterior, whereas expression of the mid-level target gene rho is expanded throughout the
trunk (Fig 6C and 6D). These results are consistent with the broad low level pMad in the sog-
gene mutant, and an absence of peak levels of BMP signaling. The sogΔdist enhancer mutant
appears to increase BMP signaling outputs; both peak response (i.e. Race) as well as mid-level
signaling output (i.e. rho) expression domains are wider, similar to the sog- heterozygous
embryos (Fig 6C and 6D). However, deletion of sogΔint leads to a mostly wildtype rho expression
Fig 5. Two coacting enhancers at the sog locus drive largely overlapping expression domains in the early embryo but differ in expression levels and sensitivity to
ventral repression, leading to opposite effects on amnioserosa specification. (A) Genomic locus of sog indicating the location of the sog.int (light green) and sog.dist
(dark green) enhancers relative to sog. Exons for sog are shown as black boxes and 5’ and 3’ UTR indicated in grey. (B-G) In situ hybridization using sog (B,E-G) or lacZ
(C,D) riboprobes detected by alkaline phosphatase (AP) on (B) WT, (C) sog.int-lacZ reporter, (D) sog.dist-lacZ reporter, (E) sogΔint, (F) sogΔdist, and (G) sogΔintΔdist
embryos. The top row of embryos is late stage 5 and the bottom row is stage 8 or 9. (H,I) FISH staining on manually cross-sectioned embryos in early stage 5 at nc14A
(H) or nc14B (I) with riboprobe to the first exon of sog which includes part of the 5’ UTR, thus labelling both nascent and mature transcripts. (J) Number of
amnioserosa cells on the lateral side of the embryo for each of the genotypes. The number of amnioserosa is significantly different from WT in the mutant embryos for
sog- gene (���P = 1.2x10-6, Welsh’s t-test), sogΔint (���P = 1.1x10-4, Welsh’s t-test), and sogΔintΔdist (���P = 1.3x10-13, Welsh’s t-test), but not for the sog- gene
heterozygote (sog-/FM7), sogΔdist, or the sog enhancer double mutant heterozygotes (sogΔintΔdist/FM7) (P = 0.18, P = 0.05, and P = 0.78, respectively, Welsh’s t-test).
https://doi.org/10.1371/journal.pgen.1008525.g005
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pattern (Fig 6D), but a decrease in Race expression (Fig 6C). This is consistent with the model of
sog overexpression where most of the Dpp ligand is sequestered and unable to activate peak
response genes. Therefore, in terms of Race expression, the two shadow enhancers at the sog
locus appear to support opposite functions. These results suggest that both sog.int and sog.dist
enhancers are required to express the proper levels of sog for both peak and mid-level BMP tar-
gets to be expressed possibly through a mechanism of enhancer competition (see Discussion).
To test for genetic interactions between the brk and sog enhancer mutants, we recombined
the three brk enhancer mutants into either the sogΔint and sogΔdist mutant backgrounds. All
double and triple mutants were homozygous viable. In addition, we found that all of the
sogΔint recombinants were epistatic to the brk enhancer mutant in terms of amnioserosa cell
number, while the brk single mutants appeared to be additive with the effect of the sogΔdist
mutant phenotype (Fig 7A). These genetic interaction results provide insight into the relative
timing of action of these enhancers; sogΔint likely acts later than either brk enhancers, whereas
sogΔdist is likely coactive with them (see Discussion, Fig 7B).
Fig 6. Shadow enhancers associated with the sog gene also exhibit opposite phenotypes relating to BMP signaling outputs. (A-D) (A) Lateral or (B-D)
dorsal view of stage 6 embryos hybridized with riboprobes to (A) sog, (C) Race, (D) rho, or (B) immunostained with an antibody to pMad and false colored
with a heatmap (key indicated to the right, red highest, black lowest expression, see Materials and methods). sog- is gene mutant, whereas sogΔint, sogΔdist, and
sogΔintΔdist are deletions of individual enhancers.
https://doi.org/10.1371/journal.pgen.1008525.g006
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Fig 7. Genetic epistasis between enhancer mutants gives insight into timing of action of sog enhancers. (A) Number of amnioserosa
cells on the lateral side of the embryo for each of the genotypes. For ease of comparison, results from all brk mutant embryos (shaded boxes)
are repeated from Fig 1, and the single sog mutant embryos are repeated from Fig 6, and placed next to the corresponding brk and sog
double mutants. Amnioserosa cells associated with 8–11 embryos were counted for each genotype. (B) Model of sog enhancer action. sog.
dist acts early driving high levels of expression of Sog and leading to an excess of Sog over Dpp resulting in predominantly sequestered
ligand. Dominance of enhancer activity switches over time and sog.int is more influential later, lowering the levels of Sog relative to Dpp,
leading to Sog levels which allow for free Dpp and signaling.
https://doi.org/10.1371/journal.pgen.1008525.g007
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Discussion
In this study, we have used a genetic loss-of-function approach to examine the roles for indi-
vidual coacting enhancers associated with the genes brk and sog in the early Drosophila embryo
learning that these enhancers are not functionally redundant but differentially impact gene
regulatory networks due to the changing roles of the gene product in time and space. Although
the examination of associated gene expression is an obvious first step in understanding their
importance, the effect on the broader gene network caused by deletion of individual coacting
enhancers has not been closely examined. Our analysis of individual enhancer functions in the
context of the gene regulatory network acting in early embryos led to three main findings:
I. Individual enhancer deletions for these genes are viable and yet provide
novel phenotypic insights
First, individual enhancer deletions for sog and brk, as well as compound embryonic enhancer
deletions for brk are viable, while the gene mutants are zygotically lethal. Despite the array of
phenotypes associated with these genotypes, the fact that they are compatible with viability
underscores the robustness of embryonic development in D. melanogaster. More importantly,
however, assay of novel phenotypes associated with these enhancer deletions allowed us to
uncover new functions for these genes that had not been previously realized by analysis of
gene mutant phenotypes.
In the case of brk, the brk3’ enhancer deletion indicates a role for Brk in specification of amnio-
serosa and establishing the dorsal border of some ventrally expressed genes. It was the unexpected
change in amnioserosa number, specifically in the brkΔ3’ embryos, that first indicated this altered
gene network state (Fig 1J and 1K). Furthermore, addition of NanoString data allowed us to
observe that in the brkΔ3’ mutants a number of genes are upregulated that are minimally affected
if at all in the other two mutant lines. Unexpectedly, several of these genes were expressed in the
ventral side of the embryo, in the presumptive mesoderm (Fig 3E–3I). This expansion of ventral
genes into the lateral neuroectodermal region in brkΔ3’ embryos highlights a previously unknown
role of Brk in repressing ventrally expressed genes. We suggest that this role is likely masked in
brk- gene mutants by the expansion of BMP signaling that is known to repress many more ven-
trally expressed genes [42]. In addition, other genes such as Neu2 and Su(H) are repressed in a
reverse additive manner, with the most repression associated with brkΔ5’ and the least repression
with brkΔ5’Δ3’ (S2 Fig). Again, this pattern demonstrates that removal of a single enhancer can
lead to a more severe outcome than removal of both early acting brk enhancers in these embryos.
We propose that analysis of gene mutants provides only partial insight into gene function, as
multiple enhancers often support spatiotemporally-diverse expression and loss-of-function phe-
notypes may bias analysis toward identification of the role of only the earliest-acting enhancer.
Altered expression resulting from individual enhancer deletions does not merely reduce expres-
sion of the gene it regulates but alters the regulatory environment within a cell in which expres-
sion governed by a later-acting enhancer acts; a novel gene network state is produced leading to
less severe but important changes distinct from those observed from gene mutants (Fig 8).
II. Mutant phenotypes associated with enhancer deletion genotypes
uncover complementary roles for pairs of shadow enhancers
Second, we uncovered that individual coacting enhancer deletions can sometimes present
opposite phenotypes suggesting these enhancers normally play complementary roles and
make nuanced, interdependent contributions to supporting gene expression. For example, the
brk enhancer mutants allowed us to more closely examine Brk’s role in the early embryo
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involving refinement of the expression of dpp and BMP target genes. Expansion of dpp, tld,
pnr, and zen patterns is present in the embryos with deletions of the brk5’ enhancer, but not
when the brk3’ enhancer alone is deleted. This shows that early stage 5 expression of brk (pre-
dominantly supported by the brk5’ enhancer) is required to properly regulate the boundaries
of canonical brk target genes involved in BMP signaling (see Fig 2). Conversely, brk expression
Fig 8. Spatiotemporal and dosage dynamics associated with brk and sog enhancers differentially affect Drosophila embryo gene network. (A) Model of
spatiotemporal changes associated with enhancer action in wildtype embryos (top row) compared to brkΔ5’ (middle row) and brkΔ3’ (bottom row). Embryo
images show spatial expression changes in brk during stage 5 driven by the brk5’ (gold) or brk3’ (blue) enhancers. Gene models to the right show changes in
gene network states. Expression of brk through enhancer 1 (i.e. brk5’) creates gene network state X which influences the expression of brk from both the
enhancer 2 (i.e. brk3’) as well as gene network state Y and Z downstream. Deletion of enhancer 1 or enhancer 2 lead to alternate gene network states (X’, Y’,
and Z’ or Y” and Z”). (B) Model of dosage changes associated with enhancer action showing the change in sog expression from moderate in wildtype (top
row), to high level in Δsog.int (middle row), and low level in Δsog.dist (bottom row). Gene models to the right show changes in the gene network state in each
of the genetic backgrounds. The changing levels of X (i.e. sog) in the enhancer mutant backgrounds combine with constant levels of other gene network
components Y (e.g. tld) to give opposite effect on gene network state Z.
https://doi.org/10.1371/journal.pgen.1008525.g008
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primarily driven by the brk3’ is required for the compensatory responses by the broader gene
network that refines the final output of BMP signaling (see Fig 4G). A simplified view of this
system is that Brk functions twice in a compound feedforward loop (Fig 8A) to support BMP
signaling outputs, ultimately affecting tissue specification such as amnioserosa. The initial
action is through the brk5’ enhancer (i.e. enh1; Fig 8A) and the subsequent action is through
the brk3’ enhancer (i.e. enh2; Fig 8A). The action of these enhancers is coordinate (i.e. brk3’
enhancer action is designed to follow brk5’ enhancer action), and when one or the other is
missing the system breaks down in alternate ways.
Analysis of the sog locus gives further credence to the theory that coacting enhancers can
support different gene functions. Slight changes in the domain of expression of Sog, as a
secreted protein, is unlikely to affect its function, but the levels of Sog in relation to the other
components of the GRN, such as Tld and Dpp, is critical (Fig 8B). Despite the lack of obvious
difference in their spatiotemporal expression when assayed by reporter constructs, the pheno-
types of the sog.int and sog.dist enhancer mutants are dramatically different. This functional
difference likely relates to slight differences in timing as well as the marked change in levels of
expression. Genetic interaction with brk enhancers suggest that sog.int acts after brk enhancers,
whereas the sog.dist enhancer acts concurrently with brk enhancers (Fig 7A). We infer from
these genetic epistasis experiments that sog.dist acts before sog.int. Through altering the levels
of gene expression over time, these enhancers may differentially affect Sog activity (Fig 7B).
We propose that the sog.int enhancer may function as a damper to downregulate levels of sog.
Later action by sog.int may regulate Sog levels to support just enough expression to locally
inhibit BMP signaling through sequestration of ligands but to support activation at a distance
following cleavage by Tld. These data are consistent with the idea that sog.dist promotes Sog’s
ability to repress Dpp locally whereas sog.int promotes Sog’s ability to activate Dpp at a dis-
tance (Fig 7B), and likely explains why the BMP target gene Race exhibits opposite phenotypes
in the sog enhancer mutant embryos (i.e. expanded versus lost, respectively). Thereby, even
enhancers with no obvious difference in temporal expression may exhibit temporally specific,
and complementary, actions.
Both of the single deletions, as well as the double deletion, for sog have markedly different
gene network outputs. Most strikingly, similar to what we described at the brk locus, the phe-
notype associated with the sog double enhancer deletion (sogΔintΔdist) is not simply an addi-
tive effect of the phenotypes exhibited by the single enhancer deletions (sogΔdist and sogΔint).
These results are understandable, however, in the context of how Sog interacts with the other
components of BMP signaling [32,43]. When Sog is upregulated (sogΔint), more Dpp is
sequestered leading to lower activation and a loss of peak level responses, such as Race. If, how-
ever, levels of Sog are downregulated (sogΔdist and sogΔintΔdist/FM7), there is more free Dpp,
but less shuttling, leading to a broader area of activation of target genes. Finally, with no Sog
present (sogΔintΔdist), there is also more free Dpp but no shuttling so that the mid-level targets
such as rho are expanded but peak levels are not reached to activate genes such as Race. The
double mutant is lethal but the single enhancer deletions are both viable. Thus, some amount
of Sog, even if levels are high or low, is necessary, as the system is able to compensate for aber-
rant levels but cannot tolerate a complete lack of Sog.
III. brk and sog function to canalize embryonic patterning, in a manner
requiring coordination of their respective coacting enhancers
Lastly, our data demonstrate that both brk and sog contribute to canalization of patterning in
the early embryo. Though it has been appreciated that brk and sog genes work redundantly to
regulate patterning in the early embryo to support refinement of expression of genes such as
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zen and dpp [11], a role for Brk in the regulation of sog had not been previously described. In
the brk mutant, the increase in sog levels (Fig 2F) as well as concomitant decrease in tsg (S4A
Fig), the cofactor which facilitates long range translocation of Dpp, could lead to more Dpp
ligand remaining sequestered by Sog in the lateral parts of the embryo and not being trans-
ported to the dorsal midline. Higher local Sog levels, produced in this way in brk mutant geno-
types, may serve as a compensatory response to the higher Dpp levels that result from loss of
brk. Thereby, as long as sog is present, the system appears able to adjust and compensate for
lack of brk. Brk has not been linked previously to canalization of patterning in early embryos,
though it has been shown to support dorsal closure at later stages when embryos are subjected
to thermal stress [44].
Canalization of dorsoventral axis patterning of the Drosophila embryo was characterized in
a previous study, which used amnioserosa cell number as an indicator [45]. The number of
amnioserosa cells was found to be tightly controlled in Drosophila melanogaster, with little
individual variation present except when two members of an identified canalization circuit,
egr and Cv-2, are both removed. Both egr and Cv-2 require early zen for expression (S5D Fig)
[45]. In the brk enhancer mutants, we also detected large variation in amnioserosa cell number
specification in both the brkΔ5’ and brkΔ5’Δ3’ embryos, suggesting the canalization circuit is
regulated by Brk. This idea is supported by ChIP-seq binding data, which show differential
binding of Brk to the pathway components at the two time points: binding to zen early, egr
late, and Cv-2 early and late (S5E–S5G Fig) [28]. In addition, the three genes are all differen-
tially expressed in the brk enhancer mutants: the loss of expression of brk early (brkΔ5’ and
brkΔ5’Δ3’) leads to a loss of egr expression, especially in early stage 5, but an expansion of Cv-2
expression; while a loss of late brk expression (brkΔ3’) gives expanded egr expression, but no
visible change in Cv-2 (S5A–S5C Fig). This lack of change in Cv-2 may explain why brkΔ3’
embryos can still regulate the number of amnioserosa cells, possible when one branch of the
canalization circuit remains intact; while the other two mutants do not properly regulate num-
ber of cells, as both branches are aberrant.
Previous studies of coacting/shadow enhancers have found that complete redundancy in spa-
tiotemporal expression driven by these elements is rare, or possibly non-existent [6]. Yet the
similar patterns of expression were thought to have evolved for evolutionary robustness of the
gene in the face of genetic or environmental perturbations. Here we have used genome editing
to manipulate individual enhancers in co-acting pairs to examine effects on target genes. The
changes in the gene network state upon removal of a single enhancer demonstrate that the slight
differences in timing, levels, and expression domain supported by these enhancers can have
much larger effects on the gene network as a whole. By working in complementary ways, these
coacting enhancers’ native functions are interdependent and serve distinct roles in the context
of dynamic gene regulatory networks, pivotal for robustness and canalization of patterning.
Materials & methods
Fly stocks and genetic crosses
All flies were reared at 23˚C on standard fly media. yw was used as a wildtype control unless
otherwise noted. Fly stocks used in this study are: brkm68/FM7c ftz-lacZ and brkM68 sogYS06 /
FM7c ftz-lacZ [11], sogY506/FM7c ftz-lacZ [46], brk 3’-evep-lacZ and brk5’-evep-lacZ [10], sog.
int-evep-lacZ [47], sog.dist-evep-lacZ [12], and His2Av–RFP fusion [Bloomington Drosophila
Stock Center (BDSC) #23650].
For CRISPR-Cas9 deletions within the genome, gRNA constructs were created by modify-
ing the pCFD4 plasmid (Addgene Plasmid #49411, [48]) to target PAM sequences flanking the
region to be deleted. flyCRISPR Optimal Target Finder (http://flycrispr.molbio.wisc.edu/tools)
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was used to identify the PAM sequences with no predicted off target hits. The gRNA plasmids
were then injected into either y2 cho2 v1 P{nos-phiC31\int.NLS}X; attP2 (III) (NIG-Fly
#TBX-0003) or y1 v1 P{nos-phiC31\int.NLS}X; attP40 (II) (NIG-Fly #TBX-0002). Stable
gRNA transgenic lines were created and then crossed to a Cas9 expressing line (y2 cho2 v1;
Sp/CyO, P{nos-Cas9, y+, v+}2A, NIG-Fly #Cas-0004). Individuals from the next generation
were screened by PCR for the deletions. Alternatively, for the sogΔint and sogΔdist, a homolo-
gous recombination cassette (HRC) was created by adding 1kb homology arms to the plasmid
pDsRed-attP (Addgene #51019, [49]) and this HRC was injected into embryos heterozygous
for the gRNA and Cas9 transgenes [49]. Progeny of the injected embryos were screened for
RFP expression in the eyes. The RFP cassette was then removed by crossing these flies with a
Cre expressing line (FM6:sna[Sco]/CyO, P{w[+mC] = Crew} (recombined from BDSC 1093
and 784), leaving only an attP site in the integration position. brkΔ5’Δ3’ was made by crossing
brkΔ5’;P{nos-Cas9, y+, v+}2A flies to FM6: brk3’gRNA flies and screening by PCR for the dou-
ble deletions. Similarly, sogΔintΔdist was created by crossing sogΔint;P{nos-Cas9, y+, v+}2A
flies to FM6: brk3’gRNA flies and injecting the heterozygous embryos with the sogΔdist homol-
ogous recombination cassette (HRC). Lines were screened for RFP in the eyes and the RFP
cassette was subsequently removed in the same way as for the single mutants. All lines repre-
sent isogenic backgrounds differing only in the gRNA line used to create the specific deletion.
In situ hybridizations and antibody stainings
Embryos were fixed and stained following standard protocols. Antisense RNA probes labeled
with digoxigenin, biotin, or FITC-UTP were used to detect reporter or in vivo gene expression
as described previously [50]. Probes for sog, aos, zen, sna, and rho were transcribed from
cDNA subcloned into pGEM-T vector or full-length cDNA as for brk (RE18244, DGRC). For
fluorescent in situ hybridization (FISH), probes were detected using Sheep anti-digoxigenin
(Life Technologies PA185378), Mouse anti-Bio (Invitrogen 03–3700), and Rabbit anti-FITC
(Invitrogen A889). Fluorescently labelled secondary antibodies were all from ThermoFisher
(used at 1:400). Enzymatic detection was performed using digoxigenin labelled probes fol-
lowed by detection with Anti-Digoxigenin-AP antibody (Sigma, 11093274910) and standard
AP staining using NBT/BCIP. Other antibodies used in this study were Hnt (1:20; DSHB
1G9), pSMAD1/5 (1:30; Cell Signaling Technology, 9516), and dpErk (1:200; Sigma, M9692).
Specific staging of embryo images is indicated in the associated figure legend. For early and
late stage 5, the shape and length of the nucleus as well as the membrane front of the cellulariz-
ing cells was used to define either early or late stage 5. Early stage 5 (nuclear cycle (nc)14 A and
B) included all embryos in nc14 (determined by nuclei number, see [22]) that are not fully cel-
lularized; while late stage 5 (nc14 C and D) included embryos that are fully cellularized with
the membrane front fully encapsulating the nucleus, but before gastrulation. Early stage 6
embryos were identified by the small indentation at the anterior of the embryo which begins
the formation of the cephalic furrow. Embryos of each genotype were imaged in bright field
through early embryogenesis. Although the time from the start of the movement of the cellu-
larizing membrane front to posterior midgut invagination varied by ±5 min from the wildtype
average of 33 min in two of the mutants (i.e. brkΔ5’ and the brkΔ5’Δ3’), there were no obvious
defects in cellularization seen in any of the mutants. Using nuclear shape and size combined
with percent cellularization to characterize developmental stage was judged to be an adequate
method to synchronously stage embryos that is independent of the genotype.
The following primers were used to generate riboprobes:
dppi-f ccagaactagaaaaccggaagc
dppi-t7-r gaaatTAATACGACTCACTATAgggCGCCTGTGCTAAAGACCCTG
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stumps-f TGGCCCAGAACATCGTCAGTTT
stumps-r-t7 gaaatTAATACGACTCACTATAgggATGAGACTTCACCTGCTCCTGGAT
tld B-f ATGTGGATGAGTGTTCAAT
tld B-r-T7 gaaatTAATACGACTCACTATAgggTCCCTTCGCTGGACCTCTCAT
Race-f ATGAGACTGTTTCTGCTAGCCCTGC
Race-T7-r
GAAAATTAATACGACTCACTATAGGGACGCAAGCAGAAGGCACAGATA
netA–f ATGATCCGTGGAATCTTGCTCCTGC
netA-T7-r
AATTTAATACGACTCACTATAGGGCTTTGCACTCATTGGCTTCCTTGGC
pnr-f ATCTCAAACCCTCGCTCAGC
pnr-T7-r aagtaatacgactcactatagggagaCGAGGTGGCCATCAGTTTGG
sog ex1-f TCAGGTTCAGTCGCTCTTGA
sog ex1-T7-r AATTTAATACGACTCACTATAGGGGTGTCGGACTCCTCGAACAT
Quantitative analysis of stainings
Embryos were sectioned along the anterior-posterior axis manually using a razor blade, and
cylindrical mid-embryo sections were mounted on the cut side allowing for imaging of the
axial plane. Percentage of embryo circumference for dpp and rho was measured using ImageJ.
First, an ellipse was fit to the outside of the embryo image, and the perimeter of this ellipse was
measured; then, an arc was manually drawn along this ellipse matching the extent of fluores-
cent signal for each gene measured. The length of the arc was measured, and a ratio of arc
length to full circumference was determined. The width of zen at stage 6 was measured using
chopped sections that were co-stained with DAPI to mark each of the nuclei. The cells express-
ing zen were counted manually. The amnioserosa cell number was counted using stage 10–13
stage embryos stained with Hnt antibody. Nuclei on the lateral side of the embryo only were
counted manually in ImageJ by planing through the z stacks and using the Cell Counter plug-
in. Box plots were created using BoxPlotR (http://shiny.chemgrid.org/boxplotr/).
The width of the pMad gradient was measured as described [45] with the exception that the
area selected for analysis was 120 μm along the D/V axis by 200 μm along the anterior-posterior
axis, with the top of the selection aligned to the developing cephalic furrow. The embryos from
different backgrounds were all collected, fixed, and stained simultaneously. Imaging was done
on a Zeiss LSM800 microscope with a 20X objective. Imaging for all backgrounds was done
within 2 days using the same settings for all collections. The width of the gradient was deter-
mined as described [51]. In short, it was assumed that the measured intensity is proportional to
the concentration plus background noise. To calculate the scaled concentration curves that mini-
mize χ2 [51], we used a custom R script. We set the maximum of the mean pMad concentration
of the WT embryos to one and the minimum of the mean concentration to zero and normalized
the mutant data to the WT data similarly as described [51]. The scaled curves were cut at 40% of
the wild type amplitude using a custom Python script to extract the intersection points and to
calculate the width. The measured widths were plotted in R using the boxplot function.
Heatmap representation of images for pMad and stumps were made in ImageJ. Z-stack pro-
jections were created using the sum slices function and then the heat map was applied using
the LUT function.
Embryonic viability assay
Grids were drawn on standard 10 cm apple juice collection plates, dividing each into 160 quad-
rants. One embryo was transferred from a two hour collection into each of the quadrants of
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the grid. The plates were aged at 25˚C in a humidified chamber for 30 hours, and the number
of hatched and unhatched embryos was manually counted. This was repeated for a minimum
of three times on different days for each genotype.
NanoString analysis
NanoString was run as described [22]. H2A-RFP live DNA marker (BDSC #23650) was
crossed into all of the brk mutant lines and nuclear morphology was observed on a Zeiss
LSM800 microscope. Embryos were collected at nc14C for each genotype. This specific stage
was determined to be when the nuclei were elongated but not yet disorganized, and the mem-
brane front (visualized in brightfield) fully encapsulates the nuclei [22]. Once extracted from
individually staged embryos, total RNA was hybridized with NanoString probes at 65˚C for 18
hours and then loaded onto the NanoString nCounter instrument for automated imaging and
barcode counting. To normalize between embryos and runs, l μl of Affymetrix GeneChip
Poly-A RNA Control was spiked into Trizol with each embryo at a dilution of 1:10000 before
RNA extraction. A total of 6 (WT, brkΔ5’Δ3’) or 5 (brkΔ5’, brkΔ3’) individual embryos were
analyzed for each genotype.
Primers used and quality control of CRISPR-Cas9 generated deletions
Individual deletion lines for brkΔ5’ and brkΔ3’ were verified by crossing deletions made with
different gRNA lines in trans to check for offsite effects. For brkΔ5’Δ3’, two independent
mutant lines made using the same gRNA pair was crossed in the same manner. No differences
were seen between the single mutant embryos and the trans-heterozygous embryos in the
expression of brk, dpp, Race, or zen so all analyses were done using a single mutant line for
each deletion.
As an additional control, transheterozygous embryos for enhancer deletions and respective
gene mutant alleles were analyzed to ensure that the phenotypes ascribed to enhancer deletions
relate to changes in brk or sog gene expression, specifically. For brk analysis, males of the geno-
type YW, brkΔ5’, brkΔ3’, or brkΔ5’Δ3’ were crossed to females of genotype brkM68/FM7 ftz-
lacZ. To identify trans-heterozygous embryos (i.e. females of genotype WT/brkM68, brkΔ5’/
brkM68, brkΔ3’/brkM68, or brkΔ5’Δ3’/brkM68) and assay for changes in amnioserosa,
embryos were stained with a combination of antibodies: anti-βGal to detect the balancer, anti-
Sxl to identify female embryos, and anti-Hnt to detect amnioserosa. Similar trends were seen
as for homozygous enhancer mutants (see S6 Fig). These trans-heterozygous lines were also
assayed by FISH for tld expression and were found to be consistent with the tld expression pat-
tern of the homozygous brk mutants (S6 Fig compare to Fig 2C). A similar control for the sog
mutants was not possible as sog is dosage dependent. We have included the phenotypes of the
sogΔintΔdist heterozygous embryos for each of the analyses in the main panel to show that the
phenotypes for the mutations are consistent with the sog- heterozygous embryos. Thus, indi-
cating that the changes in expression are due to changes, specifically, in sog expression and not
due to second site mutations.
Primers to make gRNA plasmids:
Set 1 (used to generation deletions at indicated loci and for phenotypic assays presented):
3’grna-f
attttaacttgctatttctagctctaaaacCGCCTCGGCCGGCGTCGCTGCgacgttaaattgaaaataggtc
3’grna-r
attttaacttgctatttctagctctaaaacCGGGGTGGAAAAGCGACCCGCgacgttaaattgaaaataggtc
5’grna-f
tatataggaaagatatccgggtgaacttcGTACCTGTTCGATCCTTCATgttttagagctagaaatagcaag
Coacting enhancers can have complementary functions
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1008525 December 12, 2019 23 / 32
5’grna-r
attttaacttgctatttctagctctaaaacTTGGGCTTTCGTTGCACAACgacgttaaattgaaaataggtc
Sog.int grna-f
tatataggaaagatatccgggtgaacttcGTCAAAATCTTTAGTTAAAGgttttagagctagaaatagcaag
Sog.int grna-r:
attttaacttgctatttctagctctaaaacTAGATCCCGGGATTTGTGCCgacgttaaattgaaaataggtc
Sog.distgrna-f:
tatataggaaagatatccgggtgaacttcGATGATAGGTGGACTCTTGATgttttagagctagaaatagcaag
Sog.distgrna-r:
attttaacttgctatttctagctctaaaacAGCGAATACGTGGAATTCCTCgacgttaaattgaaaataggtc
Set 2 (second independent generation of deletions used to test for 2nd site mutations):
3’grna2-f
tatataggaaagatatccgggtgaacttcGTTCCAAAACTTTAATCTGTTgttttagagctagaaatagcaag
3’grna2-r attttaacttgctatttctagctctaaaac
GCAATCATTCTTCAATTCATCgacgttaaattgaaaataggtc
5’grna2-f
tatataggaaagatatccgggtgaacttcGACCCGATGAAGGATCGAACgttttagagctagaaatagcaag
5’grna2-r
attttaacttgctatttctagctctaaaacGCTTTCGTTGCACAACTTTAgacgttaaattgaaaataggtc
HDR templates:
Sog.int LA-DSR-f gtacgtgaattccgaaactcgcgtgtgttatcta
Sog.int LA-DSR-r ctagcggcggccgctaactaaagattttgactagt
Sog.int RA-DSR-f gtacgtggcgcgccatcccgggatttgtgcc
Sog.int RA-DSR-r ctagcgctgcaggcggcagacagttgaataaa
Sog.dist LA-DSR-f gtacgtcccgggtccatccccacaccatttat
Sog.dist LA-DSR-r ctagcggcggccgcgaatacgtggaattcctttcg
Sog.dist RA-DSR-f gtacgtactagtaagagtccacctatcatcccagt
Sog.dist RA-DSR-r ctagcgggcgcgccagatgcgccagaagtacg
CRISPR-Cas9 Deletions:
Deleted base pairs capitalized. Indel/added sequence shown in bold italics.
brkΔ5’:
tggtattaaaactgaaaatcaatctaaaaatcaaccattgataacattttattgaatcaaaccaaaagccaaattgattcctgaatccaa
aagacccgatgaaggatcgaacaggtactacgatgatattggtcgGAAAATACCTGCGCATCCTGGTGGTTTA
TGGTGCGGCCGTAAATGCAAGCCAAGTTCTTTACGGCTTCTCTGGCACAAACCCTA
AATGTGGATTACGCTAATATTGCCCCCCCTAATAAAAACGGTCGTTGTCCAGGGCC
GAATATTGCGTCTGATTGGTTTTTCCCACGATTACAATTAGCCGGACGGACACAAA
CTGACCTGAGCTGACCCGCAAAAAGACACGGTTGTCCGGCAGTCGGAACTGAAGG
AAACTAAAGGAAACTGAGGGCAGGTCAGCGCTATGGATTGTGCACTAAGTTGCTT
AATCCGACGGGAAATCCAAAACACAACCCGAGCCCGATCCTTCGCTCCTTCGATTT
AAGCCAAAGTTAGAGGCACAGGCACACATGTGTGTTTGGTTTGAACGGGAAAGCC
CCATTTTAAAGCTGGCCAACCAACGGCAACACATGTTCATGTTAGGACCGATACAG
GTTGACATTCCCTGGAAGGATGCACCTCTGGGAGATTCCCACAACCGGCAGCAGG
TCATGTCCAACCGATCGTTGCGGGAGCCACTTGTCCCGAAAAAATCCAAAGAAACT
ATCAAGTGGCGTTTAGGGAAACTCAAAACTTTCCAACCACACCATATCTTTCTAAC
GCCACACAATAAACTGGTATGATCACTGTTAAGATCAAAATGGGCTAAATAAAGCG
ATCATGAATCATTTACTATAAACTGAAGAGTTTTCTATTCTTTAATATAAAAGAAAA
GATGAGTAACACCCTACAAAAATTTTAGGACTACAGATCTACCCACCGATGATGAT
CAACCCTTCCCAAAAAAAAGTCACAGCTTGTATTTCGTAAAGATTTCAGATTTCTT
AAGACACGATCACCAACTGATCTATGGACTTCTTAAACCATTGGGCTTTCGTTGCA
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CAACTTTAGGGATTTGTTTTTTTTTTTTTTTTTTTGATTCCACATCCGATTTCTTCTT
CGAAGCACTTCGATCTTTTCTCacatcagtttgatcgacaatcgacgatcgatggctgtgtgaaaacaagtttcgtaac
tatgtaaattaacctcca
brkΔ3’:
cgagacgggcagaaagaacgagaggaatggagatagagggGGAGAGCAGAGAGCAAGCAGGAGCCAA
GAGGCAAAGCCAAAAGAAATGCGTTTCTTTTATTTTTGACGCGTCTTAGATTCTTC
CTCTGCCGCTTCTTCTCTCGTTTTTTTCTTTCACTTTTTTGTTTTTTTTTTTTTTGTTT
TTGATTTCTTGGAATCGCATCTACTTTGAACCTTCCACGTTCCGACGGAAGACTCA
GAGACTCGACTGCATTGTATATTTGAATTTCATTTCAATTTAAATACGATTTTCTAT
GAAAATGCACGCACCACAAATACGTGCAATCGTTATCCAAACCATCTACCCCTCCC
CTCCTCCCCTTTATCACCATGCTCTTTGCCTCCGCCGTCCTCTGCTTTTTTTTTGTTT
TTTACCCCATACATGTACATAATACGATCCAAGTTTCATGAAAAAAACCGGAGAAA
CAAATTGATCATGTTTTGAATGCATTTCTGTTTGATTTCAATTTCGATTTGTGTACT
CCATAAATGCGAAAGAATCTTGGATTGGAGTTGGGGGGATAAAATGGATGGATAT
ATGGGGTGGGGTAAATCAGAATTATACGGCATATGCGGATCTAATCTAATAATATA
CAATATTACTGAGTCGCATACCCTAGAAATCGCACATTGATTAGCACAACCTGTCC
AAATTATCCGAGCAAAATCCCCCCAAATCACGCAACACTCTAAACTGATCCGAAAG
ATCCTAACAGTTGAAAATCCACCTAGTCGAGCTAAAACCAAATTGTCAGAGGATTG
CCTTGAATGGCCCACTTAAGCCAGGCGTGCGGCTGAAAGGAGCCGAGGATTCCTT
GCCGAATCCGAATCGGAATCCTGTGCCAAGGACAGCATGCAACGCACCGATGCGA
GTGCCGAATGACCTTTGGGAAAATACGTGTTGATCGACATCCATCGGCAATTGTTT
GAGATCTTCGGAAATCTCTCACCTTTCGAATGGGAAATTCCTTAGGATCATCGAGC
TAGCTGGTCAGAGAAGGCCGTTCATAAGCATGCAAATAAAGATTTCACACCTCGGC
CAGCGCACTAGGGTGCATGGTGCAGCATAGGGCTCTCAGCCAAAGGACACGAAAC
GAAATGCATGGAGATCGGGACACCTGGGAAATACCCAACCTGCCCGAAACATATG
GACGCACAACGCACAGGAGGGATCTCTCGCTCTGAATGGAAAGCAGAAACTCTCT
ATAGGCACTAGCTATCCATCCAAGTGGTTCCCGAAAAAAAAAACCCTCACAATATA
ATTCGTAAATCCCAGCCGCAGGTATTTAGTTCCGCCTTTGTCCATCTTTGGAATTCC
CAATGCTATTATTGCACCTAAGCCACTGGAGTGGGAGGTTTTGCAGTGTGTGTGCG
CGTTGCAAGTTGCTGCCGGTGAGCAACACATCGAATTCGTCCCATCTCTGTCTGGC
CGCGACTCGTCATCTCTCTCTCTCTCTCTCTCTCTCTGATCTCTCTGTCCCGCTCTG
GTTCGTGCTCTTGCTGTCGCCGGCGCCGCAGGTCAACAGCGATGTGTGGCATTTT
CTAACAGTTGCTGCTGCTGTCGCAGGTTGCAGGTTGCATGTTTTGTTGCAGTTGC
TGCAGCTTATATGACGCTTACATTTGTTATATGTATCTGCCACTGGGGGTTTTCCGT
CAATATTGCAGGTTGCATAGCTTATGCTGCAGCTTCTATTGATGACTAATTTATTGT
TGCTTGCTTGCTTGAGCAAGTTGCTTTAGGTTTACATTAAAACGGCACATTTCTTG
GCATCAGTTGCACTCTCTGTTGGTATAATTGTTGCTGTTTCTAGTATCAAGTGTACT
AATGTTGCAGGTGCTGCGCATGCATATGTTGCAAGTCTGTTGTTTATTGTAATGTA
CCCATAAAACTGCATATATTTATACATAGGTGTTTAGATTTCTACTATTATCGCTGA
AAACTTGTTTTTCTATTCAATCTTGCTCATAAAATGGTTCAAATATATATAGATTTG
CTGCACTCCCGACTTAATTCTTCCAAAATGGCTGTTAAATTTCAAACTATTGCCCAT
GTTGTTTTCGTTTAAATCGCTTATGGTTTTTCGGATGTTGTTTTTCGTTCAATCGCT
GGCTGATTTTCTTGCTCTCCCGAAAATCCACACGCACATTTTCATTGTCGACAAATT
TTCAGACGGCAGGACAAAGAATTTTTCATTCGTTTGTTTTCCACGCACTCGGTCTG
AATGGCCAAAAAGGAAAATGTGACGAGCTAGAGGGAAATAGGGCACATTTTTGGG
GGCAAGCGAGATGACCAAAAAAGACCTGCGATCCGTTCCGATCCGCTCCGGGTCG
CTTTTCCACCCCgggggcattgttttcagaccgagagtatatagtagaatctcctattatatcttctattcctatttgtatttgtatt
tgta
brk3’ in brkΔ5’Δ3’:
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gaagcgaatgccaatgcacaaggagctaaacgagtgcgagcgagacgggcagaaagaacgagaggaatggagatagagggAG
CAGGAGCCAAGAGGCAAAGCCAAAAGAAATGCGTTTCTTTTATTTTTGACGCGTC
TTAGATTCTTCCTCTGCCGCTTCTTCTCTCGTTTTTTTCTTTCACTTTTTTGTTTTT
TTTTTTTTTGTTTTTGATTTCTTGGAATCGCATCTACTTTGAACCTTCCACGTTCCG
ACGGAAGACTCAGAGACTCGACTGCATTGTATATTTGAATTTCATTTCAATTTAAA
TACGATTTTCTATGAAAATGCACGCACCACAAATACGTGCAATCGTTATCCAAACC
ATCTACCCCTCCCCTCCTCCCCTTTATCACCATGCTCTTTGCCTCCGCCGTCCTC
TGCTTTTTTTTTGTTTTTTACCCCATACATGTACATAATACGATCCAAGTTTCATG
AAAAAAACCGGAGAAACAAATTGATCATGTTTTGAATGCATTTCTGTTTGATTTCA
ATTTCGATTTGTGTACTCCATAAATGCGAAAGAATCTTGGATTGGAGTTGGGGGG
ATAAAATGGATGGATATATGGGGTGGGGTAAATCAGAATTATACGGCATATGCGG
ATCTAATCTAATAATATACAATATTACTGAGTCGCATACCCTAGAAATCGCACATT
GATTAGCACAACCTGTCCAAATTATCCGAGCAAAATCCCCCCAAATCACGCAACA
CTCTAAACTGATCCGAAAGATCCTAACAGTTGAAAATCCACCTAGTCGAGCTAA
AACCAAATTGTCAGAGGATTGCCTTGAATGGCCCACTTAAGCCAGGCGTGCGGCT
GAAAGGAGCCGAGGATTCCTTGCCGAATCCGAATCGGAATCCTGTGCCAAGGACA
GCATGCAACGCACCGATGCGAGTGCCGAATGACCTTTGGGAAAATACGTGTTGAT
CGACATCCATCGGCAATTGTTTGAGATCTTCGGAAATCTCTCACCTTTCGAATGGG
AAATTCCTTAGGATCATCGAGCTAGCTGGTCAGAGAAGGCCGTTCATAAGCATGC
AAATAAAGATTTCACACCTCGGCCAGCGCACTAGGGTGCATGGTGCAGCATAGG
GCTCTCAGCCAAAGGACACGAAACGAAATGCATGGAGATCGGGACACCTGGGAA
ATACCCAACCTGCCCGAAACATATGGACGCACAACGCACAGGAGGGATCTCTCGC
TCTGAATGGAAAGCAGAAACTCTCTATAGGCACTAGCTATCCATCCAAGTGGTTCC
CGAAAAAAAAAACCCTCACAATATAATTCGTAAATCCCAGCCGCAGGTATTTAGT
TCCGCCTTTGTCCATCTTTGGAATTCCCAATGCTATTATTGCACCTAAGCCACTGG
AGTGGGAGGTTTTGCAGTGTGTGTGCGCGTTGCAAGTTGCTGCCGGTGAGCAACA
CATCGAATTCGTCCCATCTCTGTCTGGCCGCGACTCGTCATCTCTCTCTCTCTCTCT
CTCTCTCTGATCTCTCTGTCCCGCTCTGGTTCGTGCTCTTGCTGTCGCCGGCGCCG
CAGGTCAACAGCGATGTGTGGCATTTTCTAACAGTTGCTGCTGCTGTCGCAGGTTG
CAGGTTGCATGTTTTGTTGCAGTTGCTGCAGCTTATATGACGCTTACATTTGTTATA
TGTATCTGCCACTGGGGGTTTTCCGTCAATATTGCAGGTTGCATAGCTTATGCTGC
AGCTTCTATTGATGACTAATTTATTGTTGCTTGCTTGCTTGAGCAAGTTGCTTTAGG
TTTACATTAAAACGGCACATTTCTTGGCATCAGTTGCACTCTCTGTTGGTATAATTG
TTGCTGTTTCTAGTATCAAGTGTACTAATGTTGCAGGTGCTGCGCATGCATATGTT
GCAAGTCTGTTGTTTATTGTAATGTACCCATAAAACTGCATATATTTATACATAG
GTGTTTAGATTTCTACTATTATCGCTGAAAACTTGTTTTTCTATTCAATCTTGCTCA
TAAAATGGTTCAAATATATATAGATTTGCTGCACTCCCGACTTAATTCTTCCAAAAT
GGCTGTTAAATTTCAAACTATTGCCCATGTTGTTTTCGTTTAAATCGCTTATGGTT
TTTCGGATGTTGTTTTTCGTTCAATCGCTGGCTGATTTTCTTGCTCTCCCGAAAATC
CACACGCACATTTTCATTGTCGACAAATTTTCAGACGGCAGGACAAAGAATTTTTC
ATTCGTTTGTTTTCCACGCACTCGGTCTGAATGGCCAAAAAGGAAAATGTGACGA
GCTAGAGGGAAATAGGGCACATTTTTGGGGGCAAGCGAGATGACCAAAAAAGACC
TGCGATCCGTTCCGATCCGCTCCGGGTCGCTTTTCCACCCCggcattgttttcagaccgagagtat
atagtagaatctcctattatatcttctattcctatttgta
sogΔint:
tcaatcgcatatccttaaagttcgaactagtcaaaatctttagttaGCGGCCGCGGACATATGCACACCTGCG
ATCATAACTTCGTATAATGTATGCTATACGAAGTTATAGAAGAGCACTAGTAAAGA
TCTCCATGCATAAGGCGCGCCAAGGGGTATTAACTGTTGCCTGTTGCTTTCGACATT
TCTACCTCCGCTGCGATTGCATAAGTTGCCAATGCCATTGCGCATACGCCGTGTCG
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TCTATATGGCTATATGGCTATATGGCTGTATGGTGCGGGGAAATCCCCGTAATCGC
AGGTAGAATTCCAGCCGGTGCCGAGGCGGGACCTGCTCGCACCTCTAATCCCGCC
AGGGTTTTCGGGACATGGGATATTCCCGACGGCACAGCATAGCACTCCGTTTTCTT
TTTTTTTTTTTATTATTATTGTGTCCAGTTTTAATCCGGAAAGCGGGAATTCCCTTC
CGCTCGCTGCCTGCACTGCGCTGCGCAGACGCATCGGCGTCCGTAAGCCGCTTAC
CAAAAAGATACGGGTATACCCAAATGGATGCCTGCCCATGTATATAGACCATTG
GGTGGTATGGACCATGGACCATAAAGCGGCACCCAATTGCAATTTGTTGCAACTCA
CACGCTTGATTAGCTGCATTTCCTGTTTGCAAACCCCCCTCCCAATACTCCCTACAC
TCATATATTATATATGCATATAAATGTATGTGTATATTGCATACTATTATGTTCCCG
AGTTGCAGTTTTTTTTTCCTTTTTTTTCCACTATTTCTTTCTTGGTTCGCTGCCGTT
GTTGCATTTTCAATTAAAAACAGATTGCGGTTTACGCTGCAGCGACTTTGAAACGT
TACTCGGCTTACACACAAAATGCAGCGCGATAGTAATGATGATTAACAGGTTATGT
TAGGGCTTAGTTGATACGCCGTAGatcccgggatttgtgccggaaccggaacgaatatcgaa
sogΔdist:
caatcgattaaaattacctctccagttgcacagatcaacggggtagtccacattccattccatcgaaaggaattccacgtattcgcGG
CCGCGGACATATGCACACCTGCGATCGTAGTGCCCCAACTGGGGTAACCTTTGAGT
TCTCTCAGTTGGGGGCGTAGATAACTTCGTATAATGTATGCTATACGAAGTTATAG
AAGAGCACTAGTGGGTAGTCCACATTCCATTCCATCGAAAGGAATTCCACGTATT
CGCTGGGCGTTTCGGGGGCGGACTGGGCATATGGGCGTGGTGGGAGGGGGTGG
GCGTCACGGGGCGTGGCCACACGTGAAACGGCTAATTTGTTGATGCAAATGCGG
GTGTGGCCTGTTCTCGGATCGGAGTCCCCAGCACGCGCCCACAAATAAATAAAT
GGCTGGAGATGGAAATGGAAACCGATGACGGGGAATAGGGAATGACGGCTGGG
TAGCGGGGGAGACGGGGATGGGAACTGGGGGGCTGGGGTCTTGGACCGAGATCG
CAGCCAATGGCGACAATTGGCATTCACCGTCGCAATTAATCATCATCACCGTCCG
ATTGACAATCGGGCCACAAATAAATCAAAATCAAAGGCATAAGAAAGCGAATGCA
GCGTCGGCATACAACTGCACTGAAAGAAAAATATGTATGAAGCTTCTGGTCAAGC
AAACCGCAAGAAGCGCATTTAAGCTCAAGTATGCTCAAGTATTTGTTGTGTAACTT
TAGATGATTCAAAATCGCTTTCTTATGTCTTTTTTGACTGCACTTGCCCTGAATTTC
GTCGAGTGTAGTTCCCAATCATTGCAACAATTCATCAAGTATGCAAACACACGCGG
CCGAATCAATCAATGGCGAGTAGTAGGAGTGCATGGAGGATGAGAAGGAGGAGAA
GTTGGTTGAGAGGTCATCGTTGCGATTCTGCGATTCAGCAGTTCCACAGAAGGTGT
CGTAATCCTGGACGCAAGGGTGCACGGACCAACTGACAGGGGCAAGTGCGTCCT
GTGCCACCAGATGACGCACGATGCGGCCGGAAAAACCCAAAATCAAAAACCGAA
AACCGAAAACCTGGTCAGAGTTTCCGAAAACCAAAGAGCCAACATCGAATGCGG
CACAATAACCCGATTGTCTGCGAATACCCACGATGATCTAGAATCGCACGGAGAG
CACTCTCACGCATCCGTGGCCATATGGGTGCGGCCAAATCGGAAATTCCCAGGAC
AGGTAGAATGCATTGGATATACGGGTATACGGATTGGAATTGGGATTGGGATTGG
GACTAGCACCAGGTTGCAACGCCCGCCAAGAAGCCAATTTAAATAAGCAGCATAA
ACAAAAGCGACAGCGTTTTATGATCCCCGCTCCTTATCCTTGCACAAGGATATCGC
CATGGCCACGCAGGTAGGAATAGCAGATATGGCGGCAATGATGCGCCAACCGCAC
TGCTTCGTCCTGGTCCTGGTCGGATGGGCTTTTCCCACGCAACCGCGACCTTATC
TGCGCCCCTTTTATGAGGCTGCATCTGTTTTCGCACCTCGATGCCGTTGGCATTAT
AGCCACATGTGTATGGTGGGAATTTCCGATCGACCAGCCTACCTGTTCCGCTGAAA
CCCGGGAATCTGTCCATCCTGAGCTTCCACACACACACACACACACACACAGGTCA
GTCGGCATCAATTGGCTGCCATAAACATATAACAATCAATATTGAATCCTTTATCG
TAGAATTTGTTGTATATGCCCATTGCAGTCCTTCGATTAAATGATGGCTAAAATGA
ATAAAATGAGTTGCTAGGTTCGAAGTAGGTGAAAACTGGTCAATAAGCCATATCC
TTTATGATTAGATATTCTAGTAATCTGGCATGAAATACACAAATATAATAGCGAGT
GATTAGTTTTATATAAGTATTTCTATTAAACCTCTAATAATTACCGCTTTACATATA
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GATTTTTTTAGTTGGATGCGGGCTTTAGTACCATATAGCTTTACCTGAATCTTATCG
TTTGCTTTGGCTGATCCCCCAGGATCTGCGACATAATGCCAAACACAAGCAACTTG
TTCGCCTGATCTTCGCAATCCCAGCAGGTTAACTACCCGATTTTATCGAGCAACAG
CAAACTCTTTGAACTGATTTGCTATATTTCATTTATGGCCGATTCCAAGTCCATGTC
CATTTCCCATTTCCATGTTCGTGTCCAAGTCCGTTGTTCGTTGTCCATTTCGATGTC
AGTCATTCATTTTTGTGCTCGACTGCTAATGCCTTAAAGCCAAAATCCATTTCGTC
GTTTGGCCATATAATCCAACATTATACATTAAATATGGCACTTGAAAGCACCGCGC
GTCTGCATGCCAATTTCAAGGCCCCTTTTCCTCCACTTCACCACCCACAGCATACC
ATCCCATATCCCACCGGAATTTTCCGATTTTCCCCATTTTCCCCCAACAACACCACC
ACCTTGCTGCGATCGCACTTGTCGCTCGCGCCGGCGCCTTCAGGGTCGTCAATTTT
TTGAGCGACATTTCGAAACGGTGGCTAAAATCACAAAAGCCAACAGAAAAAAATA
AAAATCAACTATGGCGAAAAAGTAATACAAATGAAATCCGAAAACAAATAAGCGA
TTTTGTTTGTGGGGAGAAATGATGATGATCGGCGCCAGACGGACATAAAAACGCC
AAAAGAAACGGAAAGGAAGCCTGGGAAAGGCGCATTTCCACTTTGTTTATTCGGA
GCTCTGAAGCTCTTTTTAATGGTTTCTTTTTTTTTTTTTTTTTGGCCAAATGGCCAA
TTAATGCGATTTACTTGATACGCTTTTGCATTTTGTTGTTGCTTTACGACGGCGGAT
ATTAATTAATTGGCCCGTCTCTGGGGAGCAATTCCCATTGTGCCCATCaagagtccacctat
catcccagttcgcagtccaaacctga
Supporting information
S1 Fig. Despite changes in brk expression patterns in the early embryo, the brk enhancer
mutants do not exhibit the cuticle phenotypes associated with brk- gene mutants. (A) Dark
field images of lateral view of cuticle preps from first instar larvae. (B) Bright field images
taken with 40X objective of dentical bands in the A2 abdominal segment. Ventral view with
anterior to the left.
(TIF)
S2 Fig. NanoString reveals changes in expression of pivotal patterning genes in brk
enhancer mutant embryos. Results for 70 genes assayed by NanoString in nc14C (late stage 5)
embryos (see Materials and methods). The results are given in arbitrary units and the SEM for
6 (WT, brkΔ5’Δ3’) or 5 (brkΔ5’, brkΔ3’) individual embryos are shown by black bars. WT
shown in black, brkΔ5’ in gold, brkΔ3’ in blue and brkΔ5’Δ3’ in grey. Genes broken into groups
based on expression level for ease of display.
(TIFF)
S3 Fig. Brk plays a role in regulating mesodermal gene expression in late stage 5 embryos.
(A-B) Screen shots from database of Brk ChIP-seq data [28] showing binding of Brk in early
stage 5 (2–2.5hr) and late stage 5 (3–3.5 hr) to the (A) netA and (B) stumps gene loci. Brk bind-
ing is significant (i.e. peak calls shown as black boxes under tracks) only in late stage 5. Flybase
defined protein coding regions for each gene shown in blue under Brk ChIP-seq tracks.
(TIF)
S4 Fig. Effects on BMP regulators and target genes varies between the brk mutant lines.
(A-C) Dorsal view of stage 6 embryos hybridized with riboprobes to (A) tsg and (B) vn, or
immunostained with an antibody to (C) dpErk. (D) Cross section of stage 6 embryos showing
zen expression (green). Magnified image shows only dorsal one-third of embryo. Representa-
tive images for each genotype, further quantified in E. (E) Box plot of width, in number of
cells, expressing zen. P-values determined by Welsh’s t-test comparing brkΔ5’, brkΔ3’, and
brkΔ5’Δ3’ to WT for zen were P = 0.4, P = 5.5x10-5, P = 0.06, respectively. Significance indi-
cated in graph by �P<0.05, ���P<0.0001. (F) Percentage of embryos showing normal (blue) vs
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disrupted (orange) expression of Race in early stage 6 embryos. Number of embryos counted
for each graph in this figure indicated under genotype.
(TIF)
S5 Fig. Brk is involved in canalizing amnioserosa and directly affects the expression of key
components of the canalization network. (A) FISH staining of early stage 5 embryos, lateral
views, with riboprobes to brk and egr. egr expression is diminished or lost in the brkΔ5’ and
brkΔ5’Δ3’ embryos. (B) In situ hybridization of late stage 5 embryos, dorsal views, with ribop-
robes to egr. egr expression remains low in the brkΔ5’ but is expanded in the brkΔ3’ embryos.
(C) FISH staining of late stage 5 embryos, lateral views, with riboprobes to Cv-2. White arrows
indicate expanded Cv-2 expression in the brkΔ5’ and brkΔ5’ Δ3’ embryos. (D) Model of canali-
zation loop acting to regulate amnioserosa cell number, reproduced from [45]. (E-G) Screen
shots from database of Brk ChIP-seq data [28] showing binding of Brk in early stage 5 (2–
2.5hr) and late stage 5 (3–3.5 hr) to the (E) egr, (F) Cv-2, and (G) zen loci.
(TIF)
S6 Fig. Changes in dorsal-lateral gene expression and amnioserosa cell number in brk
CRISPR mutants is specific to changes in brk expression. (A-E) FISH staining of late stage 5
embryos, lateral views, with riboprobes to tld (green), ind and sna (both purple). All embryos
are trans-heterozygous females of the genotypes indicated. Consistent with the patterns seen
in the homozygous brk CRISPR mutants, tld is expanded ventrally, beyond the domain of ind
expression in the trans-heterozygous embryos with brkΔ5’ and brkΔ5’ Δ3’ but not significantly
in brkΔ3’. (F) Comparison of number of amnioserosa cells in homozygous brk enhancer
mutants to trans-heterozygous combinations with brk- gene mutant. Homozygous mutant
data is reproduced from Fig 1 and placed next to the trans-heterozygous data for comparison.
(TIF)
S1 Dataset. Numerical data associated with each graph. Excel file containing raw counts for
all graphically represented data depicted in Figs 1, 2, 4, 5 and 7, S1 Fig, S2 Fig, S4 Fig, and S6
Fig.
(XLSX)
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